BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 15033417)

  • 1. The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro.
    Mazzio EA; Reams RR; Soliman KF
    Brain Res; 2004 Apr; 1004(1-2):29-44. PubMed ID: 15033417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of enhancing mitochondrial oxidative phosphorylation with reducing equivalents and ubiquinone on 1-methyl-4-phenylpyridinium toxicity and complex I-IV damage in neuroblastoma cells.
    Mazzio EA; Soliman KF
    Biochem Pharmacol; 2004 Mar; 67(6):1167-84. PubMed ID: 15006552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of cardiolipin in palmitate-treated GL15 glioblastoma cells favors cytochrome c release from mitochondria leading to apoptosis.
    Buratta M; Castigli E; Sciaccaluga M; Pellegrino RM; Spinozzi F; Roberti R; Corazzi L
    J Neurochem; 2008 May; 105(3):1019-31. PubMed ID: 18182042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells.
    Tirmenstein MA; Hu CX; Scicchitano MS; Narayanan PK; McFarland DC; Thomas HC; Schwartz LW
    Toxicol In Vitro; 2005 Jun; 19(4):471-9. PubMed ID: 15826805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of hydrogen peroxide and acrolein-induced oxidative stress, mitochondrial dysfunctions and redox regulated pathways by the Bacopa monniera extract: potential implication in Alzheimer's disease.
    Singh M; Murthy V; Ramassamy C
    J Alzheimers Dis; 2010; 21(1):229-47. PubMed ID: 20421692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of 6-hydroxydopamine: live cell imaging of cytoplasmic redox flux.
    Dooley CT; Li L; Misler JA; Thompson JH
    Cell Biol Toxicol; 2012 Apr; 28(2):89-101. PubMed ID: 22228498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.
    Hajieva P; Mocko JB; Moosmann B; Behl C
    J Neurochem; 2009 Jul; 110(1):118-32. PubMed ID: 19486265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression.
    Fernandez-Gomez FJ; Pastor MD; Garcia-Martinez EM; Melero-Fernandez de Mera R; Gou-Fabregas M; Gomez-Lazaro M; Calvo S; Soler RM; Galindo MF; Jordán J
    Neurobiol Dis; 2006 Nov; 24(2):296-307. PubMed ID: 16978869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malonate induces cell death via mitochondrial potential collapse and delayed swelling through an ROS-dependent pathway.
    Fernandez-Gomez FJ; Galindo MF; Gómez-Lázaro M; Yuste VJ; Comella JX; Aguirre N; Jordán J
    Br J Pharmacol; 2005 Feb; 144(4):528-37. PubMed ID: 15655518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease.
    Cai X; Jia H; Liu Z; Hou B; Luo C; Feng Z; Li W; Liu J
    J Neurosci Res; 2008 Dec; 86(16):3622-34. PubMed ID: 18709653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro.
    Dykens JA; Jamieson J; Marroquin L; Nadanaciva S; Billis PA; Will Y
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):203-10. PubMed ID: 18817800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain.
    Kaur P; Radotra B; Minz RW; Gill KD
    Neurotoxicology; 2007 Nov; 28(6):1208-19. PubMed ID: 17850875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells.
    Gomez-Lazaro M; Bonekamp NA; Galindo MF; Jordán J; Schrader M
    Free Radic Biol Med; 2008 Jun; 44(11):1960-9. PubMed ID: 18395527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cellular energy status in tocopheryl hemisuccinate cytoprotection against ethyl methanesulfonate-induced toxicity.
    Ray SD; Fariss MW
    Arch Biochem Biophys; 1994 May; 311(1):180-90. PubMed ID: 8185315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of vitamin E and vitamin C and inhibition of brain mitochondrial oxidative phosphorylation by peroxynitrite.
    Vatassery GT; Lai JC; DeMaster EG; Smith WE; Quach HT
    J Neurosci Res; 2004 Mar; 75(6):845-53. PubMed ID: 14994345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA.
    Hauptmann N; Grimsby J; Shih JC; Cadenas E
    Arch Biochem Biophys; 1996 Nov; 335(2):295-304. PubMed ID: 8914926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging.
    Wei YH; Wu SB; Ma YS; Lee HC
    Chang Gung Med J; 2009; 32(2):113-32. PubMed ID: 19403001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial alterations related to programmed cell death in tobacco cells under aluminium stress.
    Panda SK; Yamamoto Y; Kondo H; Matsumoto H
    C R Biol; 2008 Aug; 331(8):597-610. PubMed ID: 18606389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.